Combining paclitaxel with repurposing drugs improve ovarian cancer management
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Rede Académica das Ciências da Saúde da Lusofonia - RACS
2022-04-01
|
| Series: | RevSALUS |
| Subjects: | |
| Online Access: | https://revsalus.com/index.php/RevSALUS/article/view/301 |
| _version_ | 1798016991322177536 |
|---|---|
| author | Mariana Nunes Catarina Brandão Sara Ricardo |
| author_facet | Mariana Nunes Catarina Brandão Sara Ricardo |
| author_sort | Mariana Nunes |
| collection | DOAJ |
| first_indexed | 2024-04-11T15:59:39Z |
| format | Article |
| id | doaj.art-daf25fc78a4443d5b3e9e1deddb1e69c |
| institution | Directory Open Access Journal |
| issn | 2184-4860 2184-836X |
| language | English |
| last_indexed | 2024-04-11T15:59:39Z |
| publishDate | 2022-04-01 |
| publisher | Rede Académica das Ciências da Saúde da Lusofonia - RACS |
| record_format | Article |
| series | RevSALUS |
| spelling | doaj.art-daf25fc78a4443d5b3e9e1deddb1e69c2022-12-22T04:15:04ZengRede Académica das Ciências da Saúde da Lusofonia - RACSRevSALUS2184-48602184-836X2022-04-014Sup10.51126/revsalus.v4iSup.301Combining paclitaxel with repurposing drugs improve ovarian cancer managementMariana Nunes0Catarina Brandão1Sara Ricardo2Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto/Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal. Institute of Biomedical Sciences Abel Salazar (ICBAS), University of Porto, 4050-313 Porto, Portugal.Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto/Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal. Faculty of Medicine, University of Porto (FMUP), 4200-319 Porto, Portugal.Differentiation and Cancer Group, Institute for Research and Innovation in Health (i3S) of the University of Porto/Institute of Molecular Pathology and Immunology of the University of Porto (Ipatimup), 4200-135 Porto, Portugal. Faculty of Medicine, University of Porto (FMUP), 4200-319 Porto, Portugal. TOXRUN – Toxicology Research Unit, University Institute of Health Sciences, CESPU, CRL, 4585-116 Gandra, Portugal.https://revsalus.com/index.php/RevSALUS/article/view/301chemoresistancecombination therapydrug repurposingovarian cancerpaclitaxel |
| spellingShingle | Mariana Nunes Catarina Brandão Sara Ricardo Combining paclitaxel with repurposing drugs improve ovarian cancer management RevSALUS chemoresistance combination therapy drug repurposing ovarian cancer paclitaxel |
| title | Combining paclitaxel with repurposing drugs improve ovarian cancer management |
| title_full | Combining paclitaxel with repurposing drugs improve ovarian cancer management |
| title_fullStr | Combining paclitaxel with repurposing drugs improve ovarian cancer management |
| title_full_unstemmed | Combining paclitaxel with repurposing drugs improve ovarian cancer management |
| title_short | Combining paclitaxel with repurposing drugs improve ovarian cancer management |
| title_sort | combining paclitaxel with repurposing drugs improve ovarian cancer management |
| topic | chemoresistance combination therapy drug repurposing ovarian cancer paclitaxel |
| url | https://revsalus.com/index.php/RevSALUS/article/view/301 |
| work_keys_str_mv | AT mariananunes combiningpaclitaxelwithrepurposingdrugsimproveovariancancermanagement AT catarinabrandao combiningpaclitaxelwithrepurposingdrugsimproveovariancancermanagement AT sararicardo combiningpaclitaxelwithrepurposingdrugsimproveovariancancermanagement |